Preemptive prophylaxis with a lipid preparation of amphotericin B for invasive fungal infections in liver transplant recipients requiring renal replacement therapy.
about
Lipid formulations of amphotericin B significantly improve outcome in solid organ transplant recipients with central nervous system cryptococcosisAspergillus infections in transplant recipients.Targeted versus universal antifungal prophylaxis among liver transplant recipientsAmphotericin B lipid complex for the treatment of invasive fungal infections.Fungal infections: their diagnosis and treatment in transplant recipients.Fungal infections in solid organ transplantation.Strategies for the prevention of infection after solid organ transplantation.Liposomal Amphotericin B (AmBisome(®)): A Review of the Pharmacokinetics, Pharmacodynamics, Clinical Experience and Future Directions.Combination therapeutic approaches for the management of invasive aspergillosis in organ transplant recipients.Multidisciplinary approach to the treatment of invasive fungal infections in adult patients. Prophylaxis, empirical, preemptive or targeted therapy, which is the best in the different hosts?Cryptococcosis in solid organ transplant recipients: current state of the scienceDiagnosis and treatment of fungal infections in allogeneic stem cell and solid organ transplant recipients.Antifungal prophylaxis in solid organ transplant recipients.Approach to the Solid Organ Transplant Patient with Suspected Fungal Infection.Cryptococcal Infection in Transplant Kidney Manifesting as Chronic Allograft Dysfunction.Caspofungin versus fluconazole as prophylaxis of invasive fungal infection in high-risk liver transplantation recipients: A propensity score analysis.Invasive aspergillosis after kidney transplant: case-control study.Randomized, double-blind trial of anidulafungin versus fluconazole for prophylaxis of invasive fungal infections in high-risk liver transplant recipients.Aspergillosis in solid organ transplantation.Aspergillus osteomyelitis after liver transplantation.Risk factors of invasive aspergillosis after heart transplantation: protective role of oral itraconazole prophylaxis.[Invasive fungal infections in patients after liver transplantation]Antifungal management practices in liver transplant recipients.Low-dose amphotericin for prevention of serious fungal infection following liver transplantation.Invasive fungal infections in low-risk liver transplant recipients: a multi-center prospective observational study.Impact of the duration of posttransplant renal replacement therapy on bacterial infections in liver transplant recipients.Poor compliance with antifungal drug use guidelines by transplant physicians: a framework for educational guidelines and an international consensus on patient safety.Trends in Risk Profiles for and Mortality Associated with Invasive Aspergillosis among Liver Transplant Recipients
P2860
Q30433949-BFC4A413-7AC2-4260-B699-EAF5881572B2Q33719294-D634CA86-A1CB-43D3-8B9C-25FD34B49238Q35194743-C3ECF8D4-6EB0-4A81-A129-FD93C05893CEQ35575017-0CADC122-37B6-495F-A004-81A165A69FACQ36206568-1A3D1147-5382-44C5-AB07-C713F8171870Q36382578-A0BB91F3-9C33-41C7-851C-8727B81EFEABQ36670902-25FD4123-1F94-4E1C-B4A1-93370D582B81Q36868273-FA1F2010-14A7-4EF7-98A6-63E7F4B661D9Q37078394-666C78B1-7624-4E15-AD5E-BA4C3E883123Q37098160-12EAEB9A-DB83-4B42-8ED9-E97B101262C4Q37226750-9EFC0A2F-4CBE-40D8-8676-FB0E43C36893Q37650317-46BCF581-260A-4151-8A47-34FB58FF56FAQ37879201-AEB079A7-C0FA-4FBE-B805-5B8F494BBEE9Q38688900-6395668C-6DB5-4E46-8A7E-AAF333AA59F8Q40047755-307A65D9-CB73-4ADA-B5AC-6AB48CA10E8EQ40855547-1BE25B4B-CEE3-4A7D-A793-3C9434C64CB1Q41483647-FC7250B9-2B95-4FB0-8396-657986C77C7BQ41673871-F24DFA12-A6E2-4BE4-9D4D-DC5F8E332F2AQ42272291-17574D27-9510-4ADF-8781-7F0F8AD8AD4FQ44211435-2A852DD9-0E07-404F-9C46-1E83D5BDCC54Q44800864-A40AF7BB-D007-4CFE-A3F8-026E9FF54EAFQ46434488-6402CEA0-44A8-413E-B214-DB4C8740BFA9Q46812014-69A0DF4E-B854-4C6F-8315-5074A28A0694Q46877345-ED01C53D-88DB-4041-9250-C21B23218082Q46903637-BE5E0211-90A1-4EC9-84D2-58F1D42AECCFQ48829443-310E40E1-CBF5-4B94-B162-0CEC987B492EQ53159378-57E02776-79D4-4221-A2E4-9C5EADCD1B5EQ57569380-96770D36-B0E8-4924-B91E-67E22CB468C7
P2860
Preemptive prophylaxis with a lipid preparation of amphotericin B for invasive fungal infections in liver transplant recipients requiring renal replacement therapy.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Preemptive prophylaxis with a ...... ing renal replacement therapy.
@en
Preemptive prophylaxis with a ...... ing renal replacement therapy.
@nl
type
label
Preemptive prophylaxis with a ...... ing renal replacement therapy.
@en
Preemptive prophylaxis with a ...... ing renal replacement therapy.
@nl
prefLabel
Preemptive prophylaxis with a ...... ing renal replacement therapy.
@en
Preemptive prophylaxis with a ...... ing renal replacement therapy.
@nl
P2093
P1433
P1476
Preemptive prophylaxis with a ...... ing renal replacement therapy.
@en
P2093
P304
P356
10.1097/00007890-200104150-00016
P577
2001-04-01T00:00:00Z